The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Filter
Locations
Result types
Type of company
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Lock keywords
Exclude keywords
Optional keywords
Los Angeles, United States
1-10 Employees
2022
My neighbor was a 6-year-old boy from central MA diagnosed with a rare pediatric brain cancer after a sports accident. There were no effective treatments and a lack of research funding. The disease eventually won despite the staggering efforts of family, friends and providers, and our community suffered greatly from the loss. Over 5% of newborns suffer from a genetic disease. These include single gene, polygenic and chromosomal disorders. Many other non-congenital diseases with genetic components are activated by environmental triggers (autoimmune, cancer, tissue injury). Sophisticated viral therapies could treat, and possibly cure, these diseases and significantly ease patient burden and improve quality of life.
+
Featured
Salve | Viral Bioengineering
... Salve Therapeutics is developing a bioengineering platform to design, model and test viral gene therapies. ...
Dongguan, China
501-1000 Employees
2017
Dongguan Vanilla Bioengineering Co., Ltd. was established in 2017. We specializes in the research and development of innovative, green and healthy tobacco alternative products. The concept of heated not burn was spread throughout the tobacco world since 2014. However, this still did not change the fact that smoking is harmful to health. Nicotine is still a carcinogen that is harmful to human health.
+
Featured
Lemon-Dongguan Vanilla Bioengineering Co., Ltd.
... Lemon-Dongguan Vanilla Bioengineering Co., Ltd. ...
101-250 Employees
1970
All principles developed by Bioengineering AG-sterile seals, temperature circuits, control thresholds and others - are the state of the art. Bioengineering AG builds a large fermentor for BASF AG, Ludwigshafen, Germany. In 2004, Bioengineering AG continues to establish benchmarks in hygiene technology with the ongoing development of new systems and enhancements in the field of biotechnology. Since the 1970s, we at Bioengineering have been working with great passion on solutions which are driven forward by research and production. The company is founded on May 3, 1972. The first products developed and brought to market are a pilot system based on the "autosteri|e" principle, the LP351 modular pilot-scale fermentor and the L1523 modular laboratory fermentor. The company delivers a 1500 L pilot system for Pfizer Ltd. A fermentor with enhanced safety standards is built for Boehringer Mannheim GmbH's Biochemica plant in Tutzing, Germany.
+
Featured
Bioengineering
... Bioengineering ...
Groningen, Netherlands
1-10 Employees
1998
Contracting IMEnz Bioengineering opens up the possibility to quickly explore new strategies and new developments for your company. Contracting IMEnz also avoids high costs of in house employment of specialised personnel and of specific project investments, while at the same time access to a great network of know-how is obtained. In our collections IMEnz has already found natural hosts that produce optically pure enantiomers of various biochemicals. IMEnz Bioengineering is a biotechnology company that carries out applied research of Industrial MICROORGANISMS and Enzymes. IMEnz develops sustainable processes to produce biobased chemicals from renewable raw materials. Also, access is given to exploring IMEnz unique strain collections to find a microorganism suited for the bioproduction of a desired biochemical or intermediate. Such organic sources can be the widespread byproducts from the agri-related industry, including food and feed producers, the paper industry, and others. Examples of products and processes that we have co-developed are: various HIGH QUALITY NUTRIENTS for fermentation; the fermentative production of CHIRAL BIOCHEMICALS; the engineering of (proteolytic) enzymes to hydrolyse proteins even under extreme conditions; libraries of microorganisms; enzyme libraries; peptide libraries; binding protein libraries; a screening system for the discovery of natural ANTI-MICROBIAL agents, to name a few.
+
Featured
IMEnz Bioengineering
... Welcome to IMEnz Bioengineering ...
Hamburg, Germany
1-10 Employees
2022
We are here to create new viable value chains based on carbon neutral biomaterials. We produce Climate Oil™ by fermenting renewable carbon from organic byproducts or CO2 from point sources, resulting in an oil with minimal carbon footprint that can be used as a direct substitute for unsustainable vegetable oils. Our goal is to help industrial partners reduce their carbon footprint and produce sustainable consumer products that contribute to generational life quality. We envision a future where a high quality of life, supported by sustainable products and services, is accessible to all. Driven by the strong interest in the products from companies and investors, the founding team decided to co-found COLIPI GmbH. With a state-of-the-art fermentation laboratory, extensive oil analysis resources and more than a decade of experience in industrial biotechnology, Colipi GmbH has earned the trust of major corporations as their preferred R&D service partner. Its track record includes the successful completion of numerous commercial projects, leading to the initiation of further collaborations. This innovative process converts CO2 with the help of O2 and H2 into single cell oil, making it a suitable feedstock for the HEFA (hydroprocessed esters and fatty acids) process and offering industrial partners the opportunity to turn their CO2 emissions into net profits.
+
Featured
Revolutionising the oil industry through cutting-edge bioengineering.
... Revolutionising the oil industry through cutting-edge bioengineering. We harness the natural microbial power of yeasts and hydrogen-oxidising bacteria, combined with German bioprocess engineering, to create highly efficient production processes. We use renewable carbon from emissions ...
Pittsburgh, United States
11-50 Employees
2015
The BIOINTERPHASE Team is passionate for the mission, scientific, creative, independent, and imaginative. Our Strategy is to make good ‘art’, operate sustainably, and seek partners to steward our technology into the world. Finally, our Culture is defined by our dedication to the mission and fed by an environment that results in organic self-management, growth, and freedom.
+
Featured
The Company | BioInterphase
... BIOINTERPHASE is a mission-driven bioengineering studio. ...
+
Featured
FREEMG | Wireless surface EMG | BTS Bioengineering
... FREEMG | Wireless surface EMG | BTS Bioengineering ...
Linköping, Sweden
1-10 Employees
2013
Our Vision is a world without corneal blindness and impaired vision. Our mission is to provide the society with natural, high quality, reliable, cost-effective bio-engineered corneal implants that meet the huge demand of the world population suffering from corneal blindness and low vision. LinkoCare corneal implants can be used both for patients with corneal blindness who need a full-thickness implant and for those who suffer from corneal vision impairment and in need of a partial-thickness implant. LinkoCare bio-engineered implants will capture a significant share of the market for corneal blindness and low vision due to their advanced functionality, safety, cost effectiveness, and long term durability over existing solutions such as human donor corneas, the prosthetic artificial corneas, and synthetic inter-corneal lenses. LinkoCare is a Swedish knowledge-intensive bioengineering company developing innovative products for sight restoration.
+
Featured
Sight Restauration I Bioengineering I Corneal Implants
... LinkoCare is a Swedish knowledge-intensive bioengineering company developing innovative medical devices for sight restoration. ...
Barcelona, Spain
251-500 Employees
2005
IBEC was established in 2005 by the Ministries of Innovation, Universities and Enterprises and Health of the Generalitat de Catalunya (Autonomous Government of Catalonia), the University of Barcelona (UB) and the Technical University of Catalonia (UPC). Today, IBEC’s relationship with the UB and UPC researchers continues to operate under a framework agreement signed in 2008. A few of IBEC’s labs are located at other sites, all of which provide the clinical, equipment or collaborative requirements specific to those groups. The common denominator shared by these new initiatives is their focus on the enormous challenge of how to make life science quantitative on any scale, taking full advantage of the unprecedented power of the convergence between nano, bio and ICT. IBEC is committed to turning research results into practical applications, providing innovative solutions to industry and to hospitals, and, ultimately, to society. From excellent research to innovative solutions, IBEC merges science and engineering for Active Ageing, Future Medicine and Regenerative Therapies.
+
Featured
Applications in Bioengineering - Institute for Bioengineering of Catalonia
... Bioengineering means confronting, understanding and solving highly complex problems in biomedicine, bringing together the tools available in the fields of experimental science, life science and engineering in all their facets. ... Read ...
Winchester, United States
1-10 Employees
2022
TJXBIO, headquatered in Singapore, a thriving biotech innovation center, will provide on-site pre- and after-sales services and technical support to T&J's global customers through our local partners. Backed by Sequoia China, T&J has over a decade of know-how in designing and manufacturing mini- and micro-scale bioreactors for both microbial fermentation and cell culture that leverage cutting-edge technologies to enable game-changing business models in the biotech industry. Our high-throughput parallel-bioreactor platform is a complete solution to empower bioprocess engineers and scientists to conduct research and development effectively and efficiently. We understand it is a big decision to invest in such an advanced system like CloudReady technology, so for a limited time, we will provide a free version of D2MS for everybody to try.
+
Featured
About | TJX Bio
... T&J Bioengineering (Shanghai) Co., Ltd. ...
Technologies which have been searched by others and may be interesting for you:
Some interesting numbers and facts about the results you have just received for Bioengineering
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 122 |
| Amount of suitable service providers | 105 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1970 |
| Youngest suiting company | 2022 |
20%
40%
60%
80%
Bioengineering, an interdisciplinary field, amalgamates principles from biology, chemistry, physics, and engineering to develop systems and technologies aimed at enhancing healthcare, agriculture, and environmental sustainability. This domain focuses on the application of engineering principles to analyze biological systems and to create solutions that address complex biological or medical problems. By integrating knowledge from various scientific disciplines, bioengineers design and fabricate products such as artificial organs, advanced prosthetics, and improved medical imaging devices. Moreover, bioengineering plays a pivotal role in the development of biocompatible materials, the engineering of functional tissue replacements, and the advancement of drug delivery systems. Its impact extends beyond medical applications to include the engineering of crops with enhanced nutritional value or increased resistance to pests and diseases, thus contributing to food security and sustainable agriculture. Additionally, bioengineering is instrumental in developing bioremediation processes to detoxify contaminated environments, showcasing its vital role in environmental conservation. The field's interdisciplinary nature fosters innovation at the intersection of biology and technology, making significant contributions to improving human health, enhancing the quality of life, and ensuring the well-being of ecosystems. Through its comprehensive approach to solving biological and medical challenges, bioengineering exemplifies the convergence of science and engineering disciplines, heralding a new era of technological advancements with broad societal implications.
1. Enhanced Sustainability
: Bioengineering promotes the development of more sustainable and environmentally friendly processes. By leveraging biological systems, it reduces reliance on non-renewable resources and minimizes ecological footprints, offering a greener alternative to traditional engineering practices.
2. Medical Advancements
: The field plays a pivotal role in advancing healthcare, from the creation of synthetic organs to improved drug delivery systems. Bioengineering innovations enable personalized medicine, offering treatments tailored to individual genetic profiles, thereby improving patient outcomes and reducing side effects.
3. Agricultural Improvements
: Bioengineering has revolutionized agriculture by developing crops that are more resistant to pests, diseases, and extreme weather. This not only enhances food security globally but also reduces the need for chemical pesticides, promoting healthier ecosystems.
4. Waste Reduction and Management
: Through the development of bio-based materials and the bio-remediation of pollutants, bioengineering offers effective solutions for managing and reducing waste. This approach not only helps in cleaning the environment but also in converting waste into valuable resources.
While evaluating the different suppliers make sure to check the following criteria:
1. Expertise and Experience
Assess their years of operation and the range and depth of their expertise in bioengineering. Look for suppliers with a proven track record in projects similar to yours.
2. Quality of Products and Services
Evaluate the quality of their products and services through certifications, customer reviews, and, if possible, samples. Ensure they comply with relevant industry standards and regulations.
3. Technological Capabilities
Confirm they utilize the latest technologies and methodologies in bioengineering, which could impact the efficiency and outcome of your project.
4. Intellectual Property Management
Ensure the supplier has a clear policy for protecting intellectual property rights, crucial for innovation and competitive advantage in bioengineering projects.
5. Scalability
Choose a supplier with the capacity to scale operations up or down based on your project needs, ensuring flexibility and adaptability.
6. Cost-effectiveness
While not compromising on quality, consider the cost-effectiveness of their offerings to ensure the best value for your investment.
7. Customer Support and Communication
Opt for suppliers who offer excellent customer service, are responsive, and maintain open lines of communication throughout the project duration.
Bioengineering plays a crucial role in the pharmaceutical industry, primarily in drug discovery and development. This field employs sophisticated bioengineering techniques, such as recombinant DNA technology, to design and produce novel drugs, including vaccines, hormones, and antibodies. By leveraging bioengineering, pharmaceutical companies can enhance the efficacy and specificity of drugs, reduce production costs, and accelerate the drug development process, making treatments more accessible to the market. In the agricultural sector, bioengineering is instrumental in developing genetically modified crops that exhibit improved yield, disease resistance, and drought tolerance. Through the manipulation of genetic material, bioengineers create crop varieties that can withstand harsh environmental conditions and pests, significantly boosting food production and sustainability. This application not only helps in meeting the global food demand but also supports farmers by reducing crop losses and increasing profitability. The healthcare industry benefits from bioengineering through the innovation of medical devices and implants. Bioengineers design and develop a wide range of products, from prosthetic limbs to organ implants and diagnostic devices, using principles from biology and engineering. These advancements improve patient care by enhancing the functionality and integration of medical devices with the human body, thereby improving the quality of life for individuals with disabilities or chronic conditions. Lastly, bioengineering has found its application in the environmental sector, particularly in waste management and pollution control. By engineering microorganisms to degrade pollutants or convert waste into biofuels, bioengineers contribute to the development of sustainable and eco-friendly technologies. This not only helps in reducing the environmental footprint of industrial processes but also paves the way for renewable energy sources, aligning with global sustainability goals.
Bioengineering, a multidisciplinary field that applies principles of engineering and biological sciences to create technologies and products to improve human health and the environment, spans various Technology Readiness Levels (TRLs) depending on the specific application or product. Generally, bioengineering technologies range from TRL 1, where basic principles are observed and reported, to TRL 9, where actual systems are proven through successful mission operations. This broad TRL range is due to the diverse nature of bioengineering projects, which include the development of medical devices, biopharmaceuticals, tissue engineering, and genetic engineering among others. For instance, in tissue engineering and regenerative medicine, many technologies are at the mid-TRL stages (4-6), where components are being validated in a laboratory environment or in relevant environments. This is because these fields face complex biological, technical, and regulatory challenges, including ensuring biocompatibility, achieving scalable manufacturing processes, and meeting stringent regulatory approvals for clinical use. On the other hand, certain bioengineered products, such as some biopharmaceuticals and medical devices, have reached TRL 9, evidenced by their widespread clinical use and regulatory approval. The specific TRL of a bioengineering technology is determined by factors such as the maturity of the underlying biological science, the development and validation of the engineering processes involved, and the successful demonstration of safety and efficacy through clinical trials.
In the short-term, bioengineering is set to revolutionize personalized medicine through advancements in gene editing techniques, particularly with CRISPR-Cas9 technology. This phase will see the refinement of targeted therapies for genetic disorders, allowing for more precise and effective treatments with reduced side effects. Additionally, the development of biocompatible materials for implants and prosthetics will enhance the integration and functionality of these devices in patients, improving quality of life for individuals with physical impairments. Mid-term developments will focus on the integration of artificial intelligence (AI) and machine learning (ML) with bioengineering to create smarter, more adaptive biomedical devices and systems. This will include bioengineered organs that can dynamically adjust and respond to the body's changing needs, as well as advanced diagnostic tools capable of predicting disease progression and response to treatment. Furthermore, the mid-term will witness significant strides in tissue engineering, including the growth of fully functional organs for transplantation, reducing the reliance on donor organs and mitigating transplant rejection issues. In the long-term, bioengineering will aim to achieve groundbreaking innovations such as the creation of synthetic life forms and the development of advanced human augmentation technologies. These advancements will explore the boundaries of extending human capabilities and longevity, including enhancing cognitive functions and physical abilities through bioengineered interfaces and cybernetic implants. Additionally, the field will likely make substantial progress in understanding and manipulating the human genome, opening possibilities for preventing genetic diseases before birth and potentially unlocking the secrets to human aging, setting the stage for a future where life expectancy could be significantly extended through bioengineering solutions.
Some interesting questions that has been asked about the results you have just received for Bioengineering
What are related technologies to Bioengineering?
Based on our calculations related technologies to Bioengineering are Education, Engineering Services, IT & Technology Services, Healthcare Services, Consulting
Who are Start-Ups in the field of Bioengineering?
Which industries are mostly working on Bioengineering?
The most represented industries which are working in Bioengineering are Biotechnology, Science and Engineering, Health Care, Data and Analytics, Professional Services
How does ensun find these Bioengineering Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
